Artery Therapeutics, Inc.
Artery Therapeutics, Inc. is a small business in San Ramon, CA registered on SAM.gov to bid on federal contracts. It has won 5 small business R&D awards worth $8.3 million through the SBIR and STTR programs since 2019, according to SBIR.gov.
- UEI
- JHVKQN55S7Y5
- CAGE code
- 62AP0
- SAM.gov registration
- Active
Registration details
| Legal business name | Artery Therapeutics, Inc. |
|---|---|
| Unique Entity ID (UEI) | JHVKQN55S7Y5 |
| CAGE code | 62AP0 |
| Location | San Ramon, CA |
| SAM.gov registration | Active through Aug 7, 2027 |
| Business started | 2004 |
| Primary NAICS code | 541714: Research and Development in Biotechnology (except Nanobiotechnology) |
| Website | arterytx.com |
SBIR and STTR awards
Artery Therapeutics, Inc. has won 5 small business R&D awards worth $8.3 million through the SBIR and STTR programs since 2019, 3 of them Phase II. Funded by NIH.
| Awarded | Agency | Project | Amount |
|---|---|---|---|
| Sep 10, 2025 | NIH | SBIR Phase II Manufacturing of ABCA1 agonist small molecule peptide CS6253 to support chronic toxicology… | $2.5 million |
| Jan 15, 2023 | NIH | SBIR Phase II A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy… | $2.5 million |
| Sep 30, 2021 | NIH | SBIR Phase I A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy… | $499,197 |
| May 15, 2020 | NIH | SBIR Phase II CS6253 development for the treatment of apoE4 driven dementia includingAlzheimer's disease | $2.4 million |
| Jun 1, 2019 | NIH | SBIR Phase I CS6253 development for the treatment of apoE4 driven dementia includingAlzheimer's disease | $479,682 |
Award data from SBIR.gov. SBIR and STTR awards are grants or contracts for R&D, so some don't appear in its federal contract history.
Federal contract history
USAspending.gov shows no federal prime contracts for this UEI in the last five years. Its SBIR and STTR awards are listed above.
NAICS codes Artery Therapeutics, Inc. is small under
On its SAM.gov registration, Artery Therapeutics, Inc. meets the SBA size standard for these industries, so it can bid on small business set-asides that use them.
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Open contracts in Artery Therapeutics, Inc.'s NAICS codes
36 open federal opportunities on SAM.gov use a NAICS code Artery Therapeutics, Inc. is small under. These are due soonest.
- SURPASS Webinar and Proposers' Day Information
Due in 2 daysOct 12, 2026
- Simulation-augmented, Real-time Platform Adaptive Seamless Trials (SURPASS)
Due in 2 daysOct 12, 2026
- UNifying Imaging with QUantum Entanglement (UNIQUE) Proposers' Day
Due in 3 daysOct 14, 2026
- Request for Information (RFI) on Identifying Basic Research Challenges to Accelerate United States Biotechnology Leadership
Due in 4 daysOct 15, 2026
- Protein ENGineering (PENG)
✦ DARPA's Defense Sciences Office wants teams to build a platform that can edit existing (endogenous) proteins inside living cells, without permanently changing DNA. It is a…
Due in 8 daysOct 19, 2026
Similar small businesses
Other small businesses with the same primary NAICS code (541714) that have won federal contracts, starting with California:
- Mapp Biopharmaceutical, Inc., San Diego, CA
- Revagenix Inc, San Mateo, CA
- Eitr Biologics, Inc., San Diego, CA
- Dnanexus, Inc., Mountain View, CA
- Vaxart Biosciences Inc, South San Francisco, CA
- Lumos Diagnostics, Inc, Carlsbad, CA
Frequently asked questions
What is Artery Therapeutics, Inc.'s CAGE code?
Artery Therapeutics, Inc.'s CAGE code is 62AP0. The Defense Logistics Agency assigns CAGE codes when a business registers on SAM.gov.
What is Artery Therapeutics, Inc.'s UEI?
Artery Therapeutics, Inc.'s Unique Entity ID (UEI) is JHVKQN55S7Y5. SAM.gov assigns the UEI, and it identifies the business across the federal government.
Is Artery Therapeutics, Inc.'s SAM.gov registration active?
Yes, as of the latest SAM.gov public data, Artery Therapeutics, Inc.'s registration is active through Aug 7, 2027. Registrations are renewed every year.
Is Artery Therapeutics, Inc. a small business?
Artery Therapeutics, Inc. is registered on SAM.gov as small under 1 NAICS code, including its primary code, 541714. Size is set per NAICS code, so a business can be small for some contracts and not others.
Keep going
- Look up another business's CAGE code or UEI
- Check a SAM.gov registration's status
- How to become a government subcontractor
Registration details come from SAM.gov's public entity extract and contract figures from USAspending.gov. Contact names and street addresses are left out. To change these details, update the registration on SAM.gov. To ask us to remove this page, email hello@fedready.us.